Avid Bioservices (NASDAQ: CDMO) reported Q3 EPS of ($0.05), versus ($0.28) reported last year. Revenue for the quarter came in at $13.8 million, versus $6.8 million reported last year.

For earnings history and earnings-related data on Avid Bioservices (CDMO) click here.